United States: Year In Review: Top Legal Developments Of 2023 - Goodwin Procter LLP

Mondaq

26 Jan 2024 0 shares 1 views

Mondaq

Published 26 Jan 2024

As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market.

Full Article

United States: Year In Review: Top Deals In 2023 - Goodwin Procter LLP

According to PWC, "2023 was a reasonably strong year for the pharmaceutical and life sciences sector with both deal value and..

Mondaq 05 Jan 2024